Nathalie LeVasseur (N LeVasseur)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Positive Breast Cancer

Sentinel Lymph Node

Top Venues

Current oncology (Toronto, Ont.)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Nathalie LeVasseur, Mita Manna, Katarzyna J Jerzak
An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management. Current oncology (Toronto, Ont.) 31 (8) (2024)
Nathalie LeVasseur, Mita Manna, Katarzyna J Jerzak
An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management. Current oncology (Toronto, Ont.) 31 (8) (2024)
Nathalie LeVasseur, Mita Manna, Katarzyna J Jerzak
An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management. Current oncology (Toronto, Ont.) 31 (8) (2024)
Nathalie LeVasseur, Karen A Gelmon
Prognostic Tests in Early-Stage Hormone Receptor-Positive Breast Cancer: An Opportunity to Refine Personalized Cancer Care. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nathalie LeVasseur, Karen A Gelmon
Reply to Y. Wang et al and Q. Sui et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mehrnoosh Pauls, Stephen Chia, Nathalie LeVasseur
Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer. Current oncology (Toronto, Ont.) 29 (7) (2022)
L Corke, L Luzhna, K Willemsma, C Illmann, M Mcdermott, C Wilson, C Simmons, Nathalie LeVasseur
Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer. Breast cancer research and treatment 194 (3) (2022)
M E Tesch, S K Chia, C E Simmons, Nathalie LeVasseur
Impact of sequence order of anthracyclines and taxanes in neoadjuvant chemotherapy on pathologic complete response rate in HER2-negative breast cancer patients. Breast cancer research and treatment 187 (1) (2021)
Nathalie LeVasseur, Wei Cheng, Sasha Mazzarello, Mark Clemons, Lisa Vandermeer, Lee Jones, Anil Abraham Joy, Pauline Barbeau, Dianna M Wolfe, Nadera Ahmadzai, Mona Hersi, Carol Stober, Risa Shorr, John Hilton, Brian Hutton
Optimising weight-loss interventions in cancer patients-A systematic review and network meta-analysis. PloS one 16 (2) (2021)
Nathalie LeVasseur, Huaqi Li, Winson Cheung, Paula Myers, Elaine Mckevitt, Rebecca Warburton, Kaylie-Anne Willemsma, Adam Deruchie Tan, Stephen Chia, Christine Simmons
Effects of High Anxiety Scores on Surgical and Overall Treatment Plan in Patients with Breast Cancer Treated with Neoadjuvant Therapy. The oncologist (2019)
Nathalie LeVasseur, J Sun, L Gondara, R Diocee, C Speers, C Lohrisch, S Chia
Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysis. Journal of cancer research and clinical oncology 146 (2) (2019)
Nathalie LeVasseur, Huaqi Li, Winson Cheung, Paula Myers, Elaine Mckevitt, Rebecca Warburton, Kaylie-Anne Willemsma, Adam Deruchie Tan, Stephen Chia, Christine Simmons
Effects of High Anxiety Scores on Surgical and Overall Treatment Plan in Patients with Breast Cancer Treated with Neoadjuvant Therapy. The oncologist 25 (3) (2019)